Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lindsey Hageman"'
Autor:
Emily Ness, Michelle Kung, Jeanette Falck Winther, Anna Sällfors Holmqvist, Daniel J. Weisdorf, Saro H. Armenian, Yanjun Chen, Ravi Bhatia, Lindsey Hageman, Liton Francisco, Smita Bhatia, Joseph Rosenthal, Kevin Battles, Mariel Parman, Mukta Arora, Donna Salzman, Jessica Wu, Stephen J. Forman
Publikováno v:
Holmqvist, A S, Chen, Y, Wu, J, Kung, M, Ness, E, Parman, M, Francisco, L, Hageman, L, Battles, K, Bhatia, R, Salzman, D, Winther, J F, Rosenthal, J, Forman, S J, Weisdorf, D J, Armenian, S H, Arora, M & Bhatia, S 2018, ' Late mortality after allogeneic blood or marrow transplantation in childhood for leukemia : a report from the Blood or Marrow Transplant Survivor Study-2 ', Leukemia, vol. 32, no. 12, pp. 2706-2709 . https://doi.org/10.1038/s41375-018-0171-4
Leukemia
Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d4f7c67afe056a03549de7dbb19c280
https://pure.au.dk/portal/da/publications/late-mortality-after-allogeneic-blood-or-marrow-transplantation-in-childhood-for-leukemia(21475f2a-d8c9-425c-8075-251cbbe1f77b).html
https://pure.au.dk/portal/da/publications/late-mortality-after-allogeneic-blood-or-marrow-transplantation-in-childhood-for-leukemia(21475f2a-d8c9-425c-8075-251cbbe1f77b).html
Autor:
Paul J. Orchard, Lindsey Hageman, Weston P. Miller, Troy C. Lund, Mukta Arora, Aman Wadhwa, Anna Sällfors Holmqvist, Michelle Kung, Mariel Parman, Yanjun Chen, Smita Bhatia, Emily Ness, Liton Francisco, Saro H. Armenian, Jessica Wu, Elizabeth A. Braunlin
Publikováno v:
Biol Blood Marrow Transplant
Allogeneic blood or marrow transplantation (BMT) is currently considered the standard of care for patients with specific inborn errors of metabolism (IEM). However, there is a paucity of studies describing long-term survival and cause-specific late m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff404620ecb11cbefb379a6157b9d534
https://europepmc.org/articles/PMC9940306/
https://europepmc.org/articles/PMC9940306/
Autor:
Saro H. Armenian, Kevin Battles, Emily Ness, Jeanette Falck Winther, Liton Francisco, Ravi Bhatia, Jessica Wu, Smita Bhatia, Daniel J. Weisdorf, Aman Wadhwa, Mukta Arora, Joseph Rosenthal, Donna Salzman, Anna Sällfors Holmqvist, Mariel Parman, Yanjun Chen, Stephen J. Forman, Michelle Kung, Lindsey Hageman
Publikováno v:
Holmqvist, A S, Chen, Y, Wu, J, Battles, K, Bhatia, R, Francisco, L, Hageman, L, Kung, M, Ness, E, Parman, M, Salzman, D, Wadhwa, A, Winther, J F, Rosenthal, J, Forman, S J, Weisdorf, D J, Armenian, S H, Arora, M & Bhatia, S 2018, ' Assessment of Late Mortality Risk After Allogeneic Blood or Marrow Transplantation Performed in Childhood ', JAMA Oncology, vol. 4, no. 12, e182453 . https://doi.org/10.1001/jamaoncol.2018.2453
Importance: Allogeneic blood or marrow transplantation (BMT) is a curative option for malignant and nonmalignant diseases of childhood. However, little is known about trends in cause-specific late mortality in this population during the past 3 decade
Autor:
Anna Sällfors Holmqvist, Jeanette Falck Winther, Mukta Arora, Stephen J. Forman, Emily Ness, Lindsey Hageman, Saro H. Armenian, Ravi Bhatia, Mariel Parman, Jessica Wu, Daniel J. Weisdorf, Joseph Rosenthal, Michelle Kung, Donna Salzman, Smita Bhatia, Liton Francisco, Yanjun Chen, Kevin Battles
Publikováno v:
Holmqvist, A S, Chen, Y, Wu, J, Battles, K, Bhatia, R, Francisco, L, Hageman, L, Kung, M, Ness, E, Parman, M, Salzman, D, Winther, J F, Rosenthal, J, Forman, S J, Weisdorf, D J, Arora, M, Armenian, S H & Bhatia, S 2018, ' Late mortality after autologous blood or marrow transplantation in childhood : a Blood or Marrow Transplant Survivor Study-2 report ', Blood, vol. 131, no. 24, pp. 2720-2729 . https://doi.org/10.1182/blood-2018-02-831156
Autologous blood or marrow transplantation (BMT) is a curative option for several types of childhood cancer. However, there is little information regarding the risk of late mortality. We examined all-cause mortality, relapse-related mortality (RRM),
Autor:
Sharon M. Castellino, Kent D. Taylor, ZoAnn E. Dreyer, Saro H. Armenian, Kevin C. Oeffinger, Wendy Landier, Javier G. Blanco, Jerome I. Rotter, Joseph P. Neglia, Smita Bhatia, Yii-Der Ida Chen, Jill P. Ginsberg, Purnima Singh, Lindsey Hageman, Leslie L. Robison, Naomi J. Winick, Can Lan Sun, Adolfo Quiñones-Lombraña, Xuexia Wang, Molly Mather, Melissa M. Hudson
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol 34, iss 8
Wang, X; Sun, C-L; Quinones-Lombrana, A; Singh, P; Landier, W; Hageman, L; et al.(2016). CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study. JOURNAL OF CLINICAL ONCOLOGY, 34(8), 863-+. doi: 10.1200/JCO.2015.63.4550. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6b77t468
Wang, X; Sun, C-L; Quinones-Lombrana, A; Singh, P; Landier, W; Hageman, L; et al.(2016). CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study. JOURNAL OF CLINICAL ONCOLOGY, 34(8), 863-+. doi: 10.1200/JCO.2015.63.4550. UCLA: Retrieved from: http://www.escholarship.org/uc/item/6b77t468
Purpose Interindividual variability in the dose-dependent association between anthracyclines and cardiomyopathy suggests that genetic susceptibility could play a role. The current study uses an agnostic approach to identify genetic variants that coul
Autor:
Smita Bhatia, Leo Mascarenhas, Alexandra Schaible, Andrea Carter, Cara Hanby, David S. Dickens, Mary V. Relling, Wendy M. Leisenring, William L. Carroll, F. Lennie Wong, Jane L. Meza, Jacqueline Casillas, Nancy Kornegay, Wendy Landier, Muyun Shangguan, Yutaka Yasui, A. Kim Ritchey, Lindsey Hageman
Publikováno v:
Journal of Clinical Oncology. 30:2094-2101
Purpose Systemic exposure to mercaptopurine (MP) is critical for durable remissions in children with acute lymphoblastic leukemia (ALL). Nonadherence to oral MP could increase relapse risk and also contribute to inferior outcome in Hispanics. This st
Autor:
Nancy Kornegay, Amanda M. Termuhlen, Heeyoung Kim, Leo Mascarenhas, Lindsey Hageman, Bruce Bostrom, Smita Bhatia, Yanjun Chen, Can Lan Sun, William L. Carroll, Anne L. Angiolillo, Glen Lew, Wendy Landier, Jacqueline Casillas, A. Kim Ritchey, Mary V. Relling, William E. Evans, F. Lennie Wong, Kelly W. Maloney
Publikováno v:
JAMA oncology. 1(3)
Variability in prescribed doses of 6-mercaptopurine (6MP) and lack of adherence to a 6MP treatment regimen could result in intra-individual variability in systemic exposure to 6MP (measured as erythrocyte thioguanine nucleotide [TGN] levels) in child
Autor:
Yaddanapudi Ravindranath, F. Lennie Wong, Bruce Bostrom, Kelly W. Maloney, Joseph P. Neglia, Yanjun Chen, Jacqueline Casillas, David S. Dickens, Heeyoung Kim, A. Kim Ritchey, Kristine R. Crews, William E. Evans, Mary V. Relling, Smita Bhatia, Lindsey Hageman, Wendy Landier
Publikováno v:
Blood. 124(15)
Durable remissions in children with acute lymphoblastic leukemia (ALL) require a 2-year maintenance phase that includes daily oral 6-mercaptopurine (6MP). Adherence to oral 6MP among Asian-American and African-American children with ALL is unknown. W